Jorge Conde

Jorge Conde is a general partner on the Bio + Health team at Andreessen Horowitz, where he focuses on life sciences and healthcare investments at the intersection of biology, computer science, and engineering. He has over 20 years of experience in the life sciences sector, including roles as Chief Strategy Officer at Syros Pharmaceuticals and co-founder and CEO of Knome, a human genome interpretation company acquired by Tute Genomics in 2015. He holds an MBA from Harvard Business School, an MS from the Harvard-MIT Division of Health Sciences and Technology, and a BA in Biology from Johns Hopkins University.